DE69224497T2 - Faktor C2a des Antibiotikums CE 2270 - Google Patents

Faktor C2a des Antibiotikums CE 2270

Info

Publication number
DE69224497T2
DE69224497T2 DE69224497T DE69224497T DE69224497T2 DE 69224497 T2 DE69224497 T2 DE 69224497T2 DE 69224497 T DE69224497 T DE 69224497T DE 69224497 T DE69224497 T DE 69224497T DE 69224497 T2 DE69224497 T2 DE 69224497T2
Authority
DE
Germany
Prior art keywords
antibiotic
factor
medicament
directed
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69224497T
Other languages
English (en)
Other versions
DE69224497D1 (de
Inventor
Enrico Selva
Sergio Stella
Luigi Colombo
Maurizio Denaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicuron Pharmaceuticals LLC
Original Assignee
Biosearch Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch Italia SpA filed Critical Biosearch Italia SpA
Publication of DE69224497D1 publication Critical patent/DE69224497D1/de
Application granted granted Critical
Publication of DE69224497T2 publication Critical patent/DE69224497T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Glass Compositions (AREA)
  • Fodder In General (AREA)
DE69224497T 1991-08-30 1992-08-12 Faktor C2a des Antibiotikums CE 2270 Expired - Fee Related DE69224497T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91114667 1991-08-30

Publications (2)

Publication Number Publication Date
DE69224497D1 DE69224497D1 (de) 1998-04-02
DE69224497T2 true DE69224497T2 (de) 1998-07-02

Family

ID=8207101

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69224497T Expired - Fee Related DE69224497T2 (de) 1991-08-30 1992-08-12 Faktor C2a des Antibiotikums CE 2270

Country Status (9)

Country Link
US (1) US5514649A (de)
EP (1) EP0529410B1 (de)
JP (1) JP3122248B2 (de)
KR (1) KR100249871B1 (de)
AT (1) ATE163428T1 (de)
CA (1) CA2077102C (de)
DE (1) DE69224497T2 (de)
DK (1) DK0529410T3 (de)
ES (1) ES2113391T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69108972T2 (de) * 1990-03-08 1995-10-19 Lepetit Spa Antibiotika GE 2270 Faktoren B1, B2, C1, D1, D2, E und T.
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
DK0808326T3 (da) * 1995-02-07 2001-10-01 Biosearch Italia Spa Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika
JP2825667B2 (ja) * 1995-02-07 1998-11-18 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ Ｇｅ２２７０及びｇｅ２２７０−様抗生物質の塩基性プロリン−アミド誘導体
JP2000505438A (ja) * 1996-02-14 2000-05-09 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ 抗生物質ＧＥ２２７０因子Ｃ▲下２ａ▼、Ｄ▲下２▼およびＥの誘導体
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
JP5230647B2 (ja) * 2006-12-20 2013-07-10 ノバルティス アーゲー アミノチアゾール大環状分子、抗菌化合物としてのその使用およびその製造法
TW200902540A (en) * 2007-06-04 2009-01-16 Novartis Ag Macrocycles and their uses
EA020205B1 (ru) 2007-12-12 2014-09-30 Новартис Аг Аминотиазолы, фармацевтические композиции на их основе и способы лечения бактериальной инфекции

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8821160D0 (en) * 1988-09-09 1988-10-12 Lepetit Spa Antibiotic ge 2270
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
ES2066914T3 (es) * 1989-07-04 1995-03-16 Lepetit Spa Factores a1, a2, a3 y h del antibiotico ge 2270.
DE69108972T2 (de) * 1990-03-08 1995-10-19 Lepetit Spa Antibiotika GE 2270 Faktoren B1, B2, C1, D1, D2, E und T.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES2113391T3 (es) 1998-05-01
JPH0649087A (ja) 1994-02-22
JP3122248B2 (ja) 2001-01-09
US5514649A (en) 1996-05-07
DK0529410T3 (da) 1998-05-11
DE69224497D1 (de) 1998-04-02
EP0529410A3 (en) 1993-05-26
KR930004471A (ko) 1993-03-22
EP0529410B1 (de) 1998-02-25
CA2077102C (en) 2002-11-12
CA2077102A1 (en) 1993-03-01
ATE163428T1 (de) 1998-03-15
KR100249871B1 (ko) 2000-03-15
EP0529410A2 (de) 1993-03-03

Similar Documents

Publication Publication Date Title
BR1100089A (pt) Novas sulfonilaminopirimidinas, sua preparação e emprego como medicamento
EP0473084A3 (en) Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides
DE69224497D1 (de) Faktor C2a des Antibiotikums CE 2270
IL81106A (en) Antibiotic composition containing a 40926 n-acyl-aminoglucuronyl aglycon and a 40926 aglycon,process for their preparation and pharmaceutical compositions containing them
ATE117724T1 (de) Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
DK0451486T3 (da) Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
ATE144780T1 (de) Megakaryocytopoietischer faktor
ES2112517T3 (es) Antibioticos ge 37468 a, b y c.
EP0359062A3 (de) Antibiotikum GE 2270
DE69107083T2 (de) Antibiotikum ge1655-komplex und seine faktoren a,b und c.
DE68906437D1 (de) L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
DK0674645T3 (da) Cephemforbindelser med antimikrobiel virkning

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: VICURON PHARMACEUTTICALS INC.(N.D.GES.STAATES DELA

8328 Change in the person/name/address of the agent

Representative=s name: DERZEIT KEIN VERTRETER BESTELLT

8339 Ceased/non-payment of the annual fee